Mutations in XLF/Cernunnos (XLF) cause lymphocytopenia in humans, and various studies suggest an XLF role in classical nonhomologous end joining (C-NHEJ). We now find that XLF-deficient mouse embryonic fibroblasts are ionizing radiation (IR) sensitive and severely impaired for ability to support V(D)J recombination. Yet mature lymphocyte numbers in XLF-deficient mice are only modestly decreased. Moreover, XLF-deficient pro-B lines, while IR-sensitive, perform V(D)J recombination at nearly wild-type levels. Correspondingly, XLF/p53-doubledeficient mice are not markedly prone to the pro-B lymphomas that occur in previously characterized C-NHEJ/p53-deficient mice; however, like other C-NHEJ/p53-deficient mice, they still develop medulloblastomas. Despite nearly normal V(D)J recombination in developing B cells, XLF-deficient mature B cells are moderately defective for immunoglobulin heavy-chain class switch recombination. Together, our results implicate XLF as a C-NHEJ factor but also indicate that developing mouse lymphocytes harbor cell-type-specific factors/pathways that compensate for the absence of XLF function during V(D)J recombination.
INTRODUCTION
The classical nonhomologous end-joining (C-NHEJ) pathway is critical for repair of general DNA double strand breaks (DSBs) in mammalian cells and for repair of programmed DSBs during lymphocyte development. There are six well-characterized C-NHEJ factors (Dudley et al., 2005) , and another, XLF/Cernunnos (XLF), that was discovered more recently Buck et al., 2006) . The Ku80/Ku70 heterodimer (Ku) binds DSBs where, among other functions, it recruits downstream C-NHEJ factors. DNA bound Ku forms a complex with and activates the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), which activates endonuclease activity of Artemis (Goodarzi et al., 2006; Ma et al., 2002; Moshous et al., 2001 ). The Artemis endonuclease processes a subset of DNA ends to prepare them for end joining (Rooney et al., 2002) . Finally, DNA Ligase IV (Lig4), in association with XRCC4, performs end ligation. Ku70, Ku80, XRCC4, and Lig4 are considered ''core'' C-NHEJ factors because they are conserved in evolution and are required for all known C-NHEJ reactions, whereas, DNAPKcs and Artemis evolved more recently and are particularly important for joining ends that require processing (Dudley et al., 2005) .
Developing B and T lymphocytes assemble immunoglobulin (Ig) and T cell receptor (TCR) variable region exons from variable (V), diversity (D), and joining (J) gene segments via V(D)J recombination. V(D)J recombination is initiated by the recombination activating gene (RAG) 1 and 2 endonuclease, which introduces DSBs between participating V, D, or J coding sequences and flanking recombination signal (RS) sequences. RAG-mediated cleavage produces two blunt 5 0 phosphorylated RS ends and two covalently sealed (hairpin) coding ends. Subsequently, C-NHEJ fuses the RS ends and the coding ends to form RS and coding joins, respectively (Dudley et al., 2005) . Core C-NHEJ factors are required for both coding and RS joins, while DNA-PKcs and Artemis are usually not required for blunt ligation of RS ends, but are instead required for coding join formation due to their role in opening and processing hairpin intermediates (Dudley et al., 2005) .
Mature B cells undergo Ig heavy-chain (IgH) class switch recombination (CSR), a process that replaces the Cm IgH constant region (C H ) exons with downstream C H exons. Long switch (S) regions that precede C H exons are targets for activation-induced cytidine deaminase (AID), an enzyme that introduces DNA lesions that lead to DSBs (Stavnezer et al., 2008) . DSBs in the donor S region upstream of Cm (Sm) are joined to DSBs in a downstream acceptor S region to complete CSR. A substantial fraction of normal CSR joins are generated by C-NHEJ, which joins ends that lack homology to form ''direct'' joins and also joins ends with several base pair homologies to form microhomology (MH) joins (Yan et al., 2007) . Thus, C-NHEJ-deficient B lymphocytes activated for CSR accumulate IgH locus chromosomal breaks and translocations due to inability to join broken S regions (Yan et al., 2007) . However, while XRCC4 and Lig4 are absolutely required for V(D)J recombination, substantial CSR (up to 50% of normal levels) occurs in their absence due to an alternative end-joining (A-EJ) pathway that strongly prefers to join ends with MH (Yan et al., 2007) . DNA-PKcs deficiency results in variably decreased CSR, and Artemis deficiency has little effect on CSR, likely in part because many broken S region ends do not require processing (Dudley et al., 2005) . However, both factors are required for some CSR joins, because their absence leads to IgH locus breaks in activated B cells (Franco et al., 2008) .
Deficiency in mice for any of the six well-characterized C-NHEJ factors results in severe combined immunodeficiency (SCID) owing to inability to complete V(D)J recombination (Dudley et al., 2005) . In addition, deficiency for these C-NHEJ factors results in increased cellular ionizing radiation (IR) sensitivity and genomic instability. Deficiency for XRCC4, Lig4, and Ku also leads to neuronal apoptosis, which, in the case of XRCC4 and Lig4 deficiency, is so severe that it causes late embryonic lethality (Lee and McKinnon, 2007) . V(D)J recombination is not completely blocked in Ku70-or Artemis-deficient mice, leading to a ''leaky'' SCID phenotype with very small populations of mature T cells (Dudley et al., 2005) . Mice that are doubly deficient for any of the six characterized C-NHEJ factors plus the p53 checkpoint protein succumb to pro-B cell lymphomas, which routinely harbor RAG-dependent translocations between IgH and chromosomal regions near the c-Myc or N-Myc oncogenes (Dudley et al., 2005) . Although they routinely die from pro-B lymphoma, C-NHEJ/p53-deficient mice also develop medulloblastomas in situ (Lee and McKinnon, 2002) , and specific deletion of XRCC4 in p53-deficient developing neurons leads to aggressive medulloblastomas with recurrent chromosomal translocations, reflecting the neuronal DSB repair defect .
Artemis mutations in humans lead to SCID (Moshous et al., 2001) . In contrast, XLF mutations in humans lead to microcephaly and a combined immunodeficiency that is less severe than that associated with Artemis mutations Buck et al., 2006; Dai et al., 2003) . XLF-deficient human fibroblasts (Buck et al., 2006; Dai et al., 2003) and mouse ES cells (Zha et al., 2007) are IR-sensitive and have DSB repair defects, including severely impaired V(D)J coding and RS joining on episomal substrates. XLF shares structural features with XRCC4, including an N-terminal head domain and a C-terminal coiled-coil domain required for homodimer formation Andres et al., 2007; Li et al., 2008) . XLF interacts with XRCC4 and boosts end ligation efficiency of the XRCC4/Lig4 complex in vitro (Gu et al., 2007; Lu et al., 2007) . XLF also stimulates end joining of mismatched noncohesive ends and blunt ends, but has little impact on ligation of cohesive ends . XLF has an apparent yeast homolog, known as Nej1 (Callebaut et al., 2006; Hentges et al., 2006) , which interacts with Lif1p, the yeast homolog of XRCC4 (Teo and Jackson, 2000) , suggesting that XLF is a ''core'' C-NHEJ factor. Although a role of XLF in C-NHEJ might explain the lymphocytopenia of human XLF mutant patients, the reason for their mildly impaired lymphocyte development is not clear. Also, one XLF mutant patient was diagnosed with hyper IgM syndrome, suggesting an XLF role in CSR (Buck et al., 2006) . To further elucidate XLF function, we generated and characterized XLF mutant mice.
RESULTS

Generation of XLF-Deficient Mice
To characterize XLF function in mouse cells, we employed genetargeted mutation to delete exons 4 and 5 from both copies of the XLF gene in ES cells (Zha et al., 2007) . The resulting XLF D/D ES cells were severely impaired for ability to form V(D)J coding and RS joins in transient assays and were IR-sensitive (Zha et al., 2007) . Expression of a wild-type (WT) XLF complementary DNA (cDNA) rescued IR sensitivity and defective V(D)J recombination in XLF D/D ES cells, confirming the specificity of the XLF targeting (Zha et al., 2007) . Our targeting strategy allowed inframe splicing from XLF exon 3 to 6 to generate a truncated XLF transcript that was readily detectable (Zha et al., 2007) . Despite truncated XLF transcripts, a cross-reactive XLF protein was not detected in XLF D/D ES cell extracts (Zha et al., 2007 Figure 1A ; see Figure S1 available online).
The crystal structure of XLF (Andres et al., 2007; Li et al., 2008 ) reveals that the potential truncated XLF protein generated by our targeting (lacking aa 131 to 196) would lack the a4 (aa 128 to 171) and a5 (aa 171 to 185) regions, which form the coiled-coil domain required for XLF homodimerization and, indirectly, for XRCC4 interaction (Andres et al., 2007; Li et al., 2008 Figure 1A ) and which were at least 50-to 100-fold higher than those of XLF Figure 2C , right panel), similar to the distribution of chromosomal abnormalities associated with deficiency for various C-NHEJ factors (Franco et al., 2008; Mills et al., 2004; Yan et al., 2007) . 
Lymphocyte Development in XLF
D/D Mice Western blot analyses of extracts from total thymus, spleen, and bone marrow of XLF D/D mice showed that expression of putative XLF Da4/5 protein occurred at levels ranging from undetectable (in some experiments titrating to less than 0.2% of authentic XLF levels in WT extracts) to very weakly detectable (less than 1% of levels of WT XLF) ( Figures 3A and S1 ). Total cell numbers in the thymus and spleens of 4-week-old XLF D/D mice were, on average, about 40%-50% those of WT ( Figure 3C ). However, flow cytometry revealed that distribution of pro-B (CD43 Figures 3B and 3C ). Reduced levels of surface CD3 and TCRb expression in ATM À/À thymocytes (Borghesani et al., 2000) might reflect a modestly impaired V(D)J recombination (Huang et al., 2007) . In this regard, XLF D/D and WT thymocytes express similar surface CD3 and TCRb levels ( Figure S4 . Values reflect two independent experiments from two independent XLF Da4/5 overexpressing ES lines (six and four copies; see Table S1 for details). and T cell development is blocked at the pro-B and double negative T cell stages in RAG2-deficient mice ( Figures 3B and 3C ) (Shinkai et al., 1992) and in all previously characterized C-NHEJ-deficient mice (Dudley et al., 2005) , owing to an inability to initiate or complete V(D)J recombination. Therefore, the relatively normal distribution of XLF D/D B and T cell populations beyond these stages suggests that V(D)J recombination occurs at relatively normal levels in developing XLF D/D lymphocytes, despite the substantial impairment of this process in XLF D/D ES cells and MEFs. To further address this possibility, we used a polymerase chain reaction approach to isolate thymocyte TCRb junctions and splenocyte IgH locus V(D)J junctions from XLF D/D and littermate control mice. Notably, all junctions recovered from XLF D/D lymphocytes, whether in frame or out of frame (e.g., not influenced by cellular selection), were similar to those recovered from corresponding populations of WT lymphocytes ( Figures S6 and S7 ). In contrast, normal V(D)J junctions were not readily isolated from previously analyzed C-NHEJ-deficient mice (Dudley et al., 2005) . Overall, our findings suggest that V(D)J recombination occurs relatively normally at endogenous loci of developing XLF D/D lymphocytes. (Bredemeyer et al., 2006) .
Molecular Cell
Western blotting confirmed lack of normal XLF protein in multiple tested XLF D/D A-MuLV transformants, and titrations indicated that, when detected, the putative XLF Da4/5 band was at less than 0.2% WT XLF levels ( Figures 4A and S1 ). To confirm the absence of physiologically active XLF, we tested for IR sensitivity and found that XLF D/D lines (n = 6) had increased IR sensitivity compared with WT and that this sensitivity was rescued by ectopic overexpression of WT XLF ( Figure 4B Figures 4B and 4C ). We employed transient transfection assays to test ability of XLF D/D A-MuLV transformants to perform V(D)J recombination on extrachromosomal substrates and found that, within the sensitivity of this assay, they generated coding and RS joins at efficiencies indistinguishable from those of WT ( Figure 4D and Supplemental Figure S8 and Table S3 ). Sequences of coding MEF lines (n = 3 for each genotype). Chromosome and chromatid breaks were scored as described (Franco et al., 2008 Figure S3 and Table S2 for details).
Functions of XLF/Cernunnos in Mice junctions from XLF D/D transformants also were indistinguishable from those of WT (Table S2) In contrast to XRCC4-deficient B cells, which lack ''direct'' CSR junctions (Yan et al., 2007) , XLF D/D B cells had a significant frequency of direct CSR joins; although the number appeared potentially less than that of WT B cells (14% versus 23%; Figure S11 ). Correspondingly, an increased proportion of the XLF D/D B cell CSR junctions had MHs; furthermore, the MHs in XLF D/D CSR junctions were longer on average ( Figure S11 ).
DISCUSSION
XLF was proposed to be a core member of the C-NHEJ pathway Buck et al., 2006; Dai et al., 2003) . Figure S7 and Table  S3 for details).
Molecular Cell
Functions of XLF/Cernunnos in Mice contain increased relative activity of a compensatory pathway/ factor compared with other analyzed cell types, which supports relatively normal V(D)J recombination in the absence of XLF.
Function of XLF and the Putative XLF Compensatory Factor
Spontaneous genomic instability in XLF D/D cells mainly occurs as chromosome breaks (Figure 2C ), suggesting that XLF, like previously characterized C-NHEJ factors, functions mainly in the repair of prereplicative DSBs. Whereas XLF-deficient MEFs show severe defects in both coding and RS joining in the context of transient V(D)J recombination assays, residual levels of both types of V(D)J recombination joins are greater than those of XRCC4-or Lig4-deficient MEFs ( Figure 2D ) (Frank et al., 1998; Gao et al., 1998b) . Correspondingly, XLF D/D MEFs do not show proliferation or premature senescence defects observed for core C-NHEJ factor-deficient MEFs (Frank et al., 1998; Gao et al., 1998b; Nussenzweig et al., 1996) . Likewise, XLF D/D ES and pro-B lines, while IR-sensitive, are not as sensitive as corresponding XRCC4-deficient lines. Although the relatively mild growth and IR sensitivity of XLF D/D cells are reminiscent of DNA-PKcs-or Artemis-deficient cells (Gao et al., 1998a; Rooney et al., 2002) , there are notable differences. First, the V(D)J coding end joining defect is much less severe in XLF D/D cells than in Artemis or DNA-PKcs-deficient cells, particularly in developing lymphocytes due to the apparent XLF compensatory mechanism. On the other hand, V(D)J joining of RS ends is much more severely impaired in XLF D/D cells other than lymphocytes (again due to the apparent compensatory mechanism) than in DNA-PKcs-and Artemis-deficient cells.
What type of activity/process compensates for normal XLF function specifically in V(D)J recombination and specifically in developing lymphocytes? One possibility is a factor that interacts with XRCC4 to directly substitute for XLF function. Alternatively, the compensatory mechanism may be indirect and may involve a factor that functions differently, but may negate the requirement for normal XLF function. In this context, given the biochemical demonstration of a preferential requirement for XLF in the joining of certain ends, end-modification factors expressed exclusively or preferentially in developing lymphocytes, such as polymerase family X members (i.e., TdT, Polm, and Poll) (Weill and Reynaud, 2008) are candidates, given their known role in V(D)J recombination but not in general DSB repair. However, while these proteins can alter V(D)J coding ends and interact with core NHEJ factors, they have no known role in RS joining (Weill and Reynaud, 2008) . Other potential candidate factors might include certain DSB response proteins, such as H2AX or ATM, that could somehow function to stabilize or otherwise alter joining of broken V(D)J ends (Bassing et al., 2003; Bredemeyer et al., 2006; Callen et al., 2007; Celeste et al., 2003) .
Unlike other core C-NHEJ factor-deficient cells, XLF D/D MEFs and ES cells make low levels of apparently normal coding and RS 
Molecular Cell
Functions of XLF/Cernunnos in Mice joins. By analogy to DNA-PKcs or Artemis deficiency, the ability of XLF-deficient nonlymphoid cells to generate low levels of normal V(D)J joins might reflect joining of certain types of ends in the absence of XLF. However, the joining efficiency of RS ends, which are generated as blunt 5 0 phosphorylated DSBs, also is impaired in nonlymphoid, but is relatively normal in lymphoid, XLF D/D cells. In addition, characterized V(D)J joins from XLF-deficient cells, thus far, shows no obvious indication of particular end preferences. Therefore, a potentially more attractive possibility would be that nonlymphoid cell types, including MEFs and ES cells, express reduced levels of a putative developing lymphocyte-specific XLF compensatory mechanism that allows normal joining of those ends with which it associates. Such a mechanism might explain similar findings that V(D)J junctions recovered from XLF mutant human fibroblasts also are largely normal despite the severely reduced V(D)J recombination efficiency (Buck et al., 2006; Dai et al., 2003) .
Implications of Mouse Studies for the Phenotype of XLF Mutations in Humans
In contrast to the SCID of Artemis-deficient patients (Moshous et al., 2001 ), XLF-mutated human patients have a variable, often moderate reduction of peripheral B cell numbers (Buck et al., 2006) . In this regard, the human phenotype is reminiscent of that of XLF D/D mice. One possible explanation for substantial numbers of mature lymphocytes in younger XLF mutant patients would be that known human mutations do not fully inactivate XLF. However, there are a variety of different XLF mutations and a number might be predicted to inactivate the protein (Buck et al., 2006) . Alternatively, based on our current findings with XLF-deficient mice, XLF also might be relatively dispensable for V(D)J recombination in developing human lymphocytes. If so, reduced numbers of human XLF mutant lymphocytes might in part reflect the role of XLF in general DSB repair, either in progen- itor or mature lymphocytes or in hematopoietic stem cells (Rossi et al., 2007) . This explanation also may be relevant to the modest reduction in XLF D/D mouse lymphocyte numbers. In this context, IgH and IgL knock-in alleles do not fully rescue lymphocyte numbers in the context of NHEJ deficiencies compared with RAG deficiency (Casellas et al., 1998) and reduced numbers of developing and peripheral mouse lymphocytes occur in the context of deficiencies for DSB response proteins (e.g., H2AX) that have no major role in V(D)J recombination (Bassing et al., 2003; Celeste et al., 2002) .
One XLF mutant patient had a hyper-IgM syndrome, with increased accumulation of IgM and a decrease of other IgH isotypes (Buck et al., 2006) ; but the underlying mechanism was unclear. Correspondingly, we observe a modest IgM increase with decreased IgG1 and, particularly, IgG3 in serum of XLF D/D mice ( Figure S11 ). In this regard, a hyper-IgM syndrome might reflect either CSR or B cell activation defects. Our mouse studies show that XLF, like other C-NHEJ factors, is required for normal CSR levels in mouse B cells. Furthermore, based on our finding of AID-dependent IgH locus chromosomal breaks in XLF D/D cells stimulated for CSR, we conclude that XLF is required for joining a subset of CSR ends. In contrast to B cells deficient for XRCC4, in which CSR is performed by a pathway extremely biased toward MH-mediated joining (Yan et al., 2007) , XLF D/D B cells generate both direct and MH-mediated CSR joins, suggesting that XLF may not be required for all CSR joins mediated by C-NHEJ.
Ectopic Bcl2 Expression Does Not Inhibit V(D)J Recombination in Mouse Pro-B Cells
Ectopic Bcl2 expression was shown to impair C-NHEJ and V(D)J recombination on episomal substrates in human cells (Wang et al., 2008) . In contrast, we show that ectopic Bcl2 overexpression in WT A-MuLV transformed B cell lines, at levels sufficient to allow the cells to withstand STI571 treatment, had no detectable effect on transient substrate V(D)J recombination including RS joining fidelity ( Figure S8 ) or on chromosomal V(D)J recombination, as indicated by lack of coding end breaks that are observed in XRCC4-deficient lines ( Figures 5B and S9) . We note that the transient V(D)J substrates used in our assays were identical to those used in studies of Bcl2-overexpressing human cells (Wang et al., 2008) . The reason for the discrepancy between the results of our studies and those with Bcl2-overexpressing human cells is unclear, but it might reflect cell type differences (lung carcinoma versus lymphocyte), species differences (human versus mouse), Bcl-2 expression level differences, or other factors. However, our findings are consistent with prior findings that normal pro-B cells, in which IgH V(D)J recombination occurs, express high Bcl2 levels (Young et al., 1997) .
EXPERIMENTAL PROCEDURES
Generation of XLF-Deficient Mice XLF +/D ES cells were generated as described (Zha et al., 2007) . Three independent XLF +/D ES cell clones were injected into C57/BL6 blastocysts to generate chimeric mice. Founder chimeras were bred to 129/Sv females, and the resulting F1 heterozygotes intercrossed to generate homozygous mutant mice in a 129/Sv background. Loss of XLF was confirmed by genomic polymerase chain reaction with three primers: F8244 5 0 -CAT GTT GGC TCT GCG AAT AGA-3 0 and R11166 5 0 -GAG TCT GGA TAT GAG CGC TCA G-3 0 for the targeted allele and F10642 5 0 -CTG TCT TGT GGG CAT AGT AGG C-3 0 and R11166 for the WT allele.
Western Blotting
Western blotting was performed using an antibody against the C terminus of XLF with the reported epitope lying between residue 250 and the C terminus of human XLF (cat. no. A300-730A-1, Bethyl Laboratories, Montgomery, TX) as described (Zha et al., 2007) .
IR Sensitivity Assays
We assayed for IR sensitivity as described . Briefly, we plated about 10 4 P1 MEFs in triplicate on day 0, irradiated with indicated doses using a
137
Cs source at day 1 and cultured for 7 days. The percentage of cells in irradiated wells versus untreated wells was plotted as a function of dose. A similar approach was used for A-MuLV-transformed pro-B cells. IR sensitivity in ES cells was measured as described (Zha et al., 2007) . For growth curves, MEFs were plated in triplicate (2 3 10 4 cells/each well of a 12-well plate) and counted every other day for 8 days.
Extrachromosomal V(D)J Recombination Assays
Substrates that test coding (pJH290) or RS join formation (pJH200) were transiently transfected into test cells together with full-length RAG1 and RAG2 expression vectors as described (Zha et al., 2007) . For ES cells, 3 3 10 6 cells were plated the day before transfection. For MEFs, 1 3 10 6 cells were used for transfection. For A-MuLV pro-B cells, 30 3 10 6 cells were used for DEAE-dextran transfection. The fidelity of RS joins and the coding join junctions were analyzed as described (Zha et al., 2007) .
Chromosomal V(D)J Recombination Assays in A-MuLV Transformants V(D)J recombination with an integrated substrate was performed as described (Bredemeyer et al., 2006) . Briefly, A-MuLV transformed pro-B cell lines were isolated from XLF D/D mice or WT mice that harbored an Em-Bcl2 transgene.
